EP2425250
METHODS FOR MONITORING THE EFFICACY OF ANTI-IL-2R ANTIBODIES IN MULTIPLE SCLEROSIS PATIENTS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
27.4.2010EP published:
26.2.2014EP application number:
10716450.1
EPO information:
European Patent Register
Max expiry date:
26.4.2030
Title:
METHODS FOR MONITORING THE EFFICACY OF ANTI-IL-2R ANTIBODIES IN MULTIPLE SCLEROSIS PATIENTS
Timeline
Today
27.4.2010EP application
26.2.2014EP Publication
Owner
Name:
AbbVie Biotherapeutics Inc.Address:
1500 Seaport Boulevard, 94063, Redwood City, CA, US
Inventor
Name:
SHERIDAN III, James PeterAddress:
Mountain ViewCalifornia, US
Priority
Number:
173138 PDate:
27.4.2009Country:
US
Classification
Categories:
G01N 33/50, G01N 33/564